Demand for weight management support has grown sharply since the arrival of GLP-1 receptor agonist medicines — semaglutide (Wegovy) and tirzepatide (Mounjaro) — in UK clinical practice. Community pharmacies are increasingly part of the pathway, both as dispensers of these medicines and as first points of contact for patients seeking NHS weight management referrals.
What weight management services do pharmacies offer?
Community pharmacies in England can support weight management through several routes:
NHS weight management referrals. Pharmacists can refer patients to local NHS weight management services, including the NHS Digital Weight Management Programme for adults with a BMI of 30 or above (or 27.5+ for certain ethnic groups) who also have diabetes, hypertension, or both. This is a structured 12-week online programme covering diet, physical activity, and behavioural change.
Dispensing GLP-1 medicines. Pharmacies dispense Wegovy and Mounjaro on NHS prescription. These injectable medicines are prescribed by GPs or specialist weight management clinics and collected from the patient's nominated pharmacy. Pharmacists counsel patients on injection technique, storage (refrigeration required), and common side effects including nausea and gastrointestinal symptoms.
Over-the-counter weight loss products. Orlistat (Alli) is available without prescription from pharmacies for adults with a BMI of 28 or above. Pharmacists assess eligibility, discuss dietary requirements (a reduced-fat diet is essential while taking orlistat), and monitor progress.
Lifestyle advice. Many pharmacies provide brief interventions on healthy eating and physical activity as part of the NHS Healthy Living Pharmacy framework. While not a formal weight management programme, these conversations can signpost patients toward more structured support.
How GLP-1 drugs have changed pharmacy workload
The introduction of Wegovy on NHS prescription in 2024-2025, followed by the expansion of tirzepatide access, has created new dispensing demand. GLP-1 receptor agonists require:
- Cold chain management. Both Wegovy and Mounjaro require refrigerated storage (2-8°C) until first use. Pharmacies dispensing these medicines need adequate fridge capacity and stock management systems.
- Patient counselling time. First-time patients need instruction on subcutaneous injection technique, dose escalation schedules, and side effect management. This takes longer than a standard dispensing interaction.
- Supply chain monitoring. Intermittent supply constraints have affected GLP-1 availability since launch. Pharmacists frequently manage patient expectations around stock and may need to liaise with prescribers about alternative dosing.
Who can get weight loss medicine on the NHS?
Eligibility for NHS-prescribed weight management medicines depends on clinical criteria set by NICE and local commissioning arrangements:
| Medicine | Route | Typical NHS criteria |
|---|---|---|
| Semaglutide (Wegovy) | SC injection, weekly | BMI ≥35 (or ≥30 with weight-related comorbidity), specialist or GP prescribing per local pathway |
| Tirzepatide (Mounjaro) | SC injection, weekly | BMI ≥35 with at least one weight-related comorbidity, via specialist weight management service |
| Orlistat | Oral capsule, 3x daily | BMI ≥28, available OTC from pharmacies or on prescription |
Criteria vary by local Integrated Care Board commissioning decisions. Not all areas offer all medicines on the same terms.
Patients who do not meet NHS criteria may access GLP-1 medicines through private prescriptions, which pharmacies can also dispense. Private prescribing for weight management has grown substantially, though pharmacists should verify the legitimacy of any private prescription and counsel patients accordingly.
What to expect at the pharmacy
If you have been prescribed a GLP-1 medicine for weight management, your pharmacy visit will typically involve:
- Collection and counselling. The pharmacist will check the prescription, confirm the dose, and — for first-time patients — explain how to use the injection pen, where to inject, and how to store the medicine.
- Side effect discussion. Nausea, vomiting, and diarrhoea are common in the early weeks, particularly during dose escalation. The pharmacist can advise on managing these.
- Follow-up. Repeat prescriptions are collected monthly. The pharmacist may ask about adherence, side effects, and whether the prescriber has scheduled a review.
For over-the-counter orlistat, the pharmacist will assess your BMI, discuss dietary requirements, and may ask about other medicines you take to check for interactions.
Finding weight management support
Community pharmacies are well placed as a first point of contact for weight management advice. You can walk in without an appointment to ask about available services, NHS referral options, or over-the-counter products.
To find pharmacies near you, including those offering enhanced services, use PharmSee's pharmacy search. For information about pharmacy services in your area, visit PharmSee's location analysis tool.
Sources: NHS England community pharmacy contractual framework; NICE guidelines TA875 (semaglutide) and TA1003 (tirzepatide); NHS Digital Weight Management Programme guidance. Information is general and does not constitute medical advice. Eligibility for specific medicines depends on individual clinical assessment.